BIOLINERX
RSS
RSS
| Careers | Contact Us
search

Investor relations home

BioLineRx is a clinical-stage, publicly-traded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel.
The Company develops products suitable for the pharmaceutical market satisfying an unmet medical need or exhibiting advantages over current therapies.

BioLineRx's close ties with universities, research institutes, academic institutions, technology transfer offices and biotech... More >>

Therapeutic pipeline
Title
Download Documentation Pipeline
Upcoming events
DateTitle
09/08/14
through
09/10/14
BioLineRx to Present at The Rodman & Renshaw 16th Annual Global Investment Conference in New York, September 8-10, 2014
09/30/14
BioLineRx will present at the 14th Annual Biotech in Europe Forum for Global Partnering & Investment at the Congress Center in Basel, Switzerland on September 30 - October 1, 2014
10/08/14
through
10/12/14
BioLineRx will present BL-5010 program (a novel formulation for the non-surgical removal of benign and pre-cancerous skin lesions) at the 23rd EADV Congress in Amsterdam, the Netherlands on October 8-12, 2014
10/18/14
through
10/22/14
BioLineRx will present BL-7040 program (an orally available oligonucleotide for the treatment of inflammatory bowel disease) at the UEG Week 2014, October 18-22, 2014 in Vienna, Austria
What's new
DateTitle
05/28/14
Download Documentation BioLineRx Company presentation
05/20/14
Download Documentation First Quarter 2014 Earnings Presentation
Get help downloading or viewing the above file types